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June Supplement 201044S Abstractsmatoma were noted in the RABAM group. There were no
deaths as a result of any procedures.
Conclusions: A transradial artery approach for balloon
angioplasty maturation of proximal arm fistulae provides at
least equivalent success rates to a standard direct fistula
approach with minimal complications.
Author Disclosures: J. Butchko: Nothing to disclose; S.
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University School of Medicine, Detroit, MI
Objectives: Hemodialysis patients may encounter severe
complications as a result of central venous hypertension. The
increasing expertise with endovascular skills offers alternative
therapeutic options, but repeat procedures are common, and
when these fail, a more definitive intervention is necessary
Methods: We reviewed the records of 3 consecutive
patients presenting with massive upper extremity edema
and functioning but threatened dialysis grafts. All patients
had central venous hypertension due to subclavian or supe-
rior vena cava obstruction. These patients were evaluated
for either endovascular or open surgical treatment
Results: No patient was found to be suitable for an
endovascular approach. All 3 patients underwent subclavian-
atrial bypass with externally supported PTFE grafts via supra-
clavicular and mini-sternotomy incisions. All 3 patients were
discharged homewithin 5 days with no postoperative compli-
cations and with significant improvement in their edema. All
of the threatened grafts continue to function at 6 months, 1
year, and 3 years. One patient developed a late steal syndrome
successfully treated by a DRIL procedure
Conclusions: A Subclavian-atrial bypass appears to be a
viable treatment alternative in patients presenting with threat-
ened dialysis grafts and symptomatic upper extremity edema
secondary to central venous hypertension
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Screening for Carotid & Renal Stenosis in Patients
Undergoing Tesio Catheter Placement
Lin Roy, Anil Hingorani, Natalie Marks, Enrico Ascher,
Alexsander Shiferson, Kapil Gopal, Daniel Jung, Theresa
Jacob. Division of Vascular Services, Maimonides Medical
Center, Brooklyn, NYObjectives: An earlier report demonstrated that if the
prevalence of significant carotid disease to be greater than
4.5%, screeningmay be cost-effective.Many factors associated
with carotid artherosclerosis are shared with those of chronic
renal disease, and those patients who have severe renal artery
disease may eventually require Tesio catheter placement.
Therefore, we postulate performing carotid/renal duplex
scans in this high-risk population may be of benefit.
Methods: Between July 2005 and August 2009, 641
patients underwent tesio catheter placement. Of these, 136
patients underwent carotid duplexes perioperatively.
Results: 13 patients (9.6%) had60% stenosis, 8 patients
(5.9%) had 70-99% stenosis, and 5 patients (3.7%) had prior
CEA procedure, eachmutually exclusive. Sex was not a signif-
icant factor in the outcome of the carotid duplex scans. Of the
109 patients who underwent renal artery duplex, renal artery
stenosis was noted in 4.9% of the patients and 2 AAA’s were
noted.
Conclusions: Our results indicates a significant preva-
lence of carotid and renal artery stenosis for patients who will
also receive Tesio catheter placement, espescially for those
with history of coronary artery disease and60 years of age.
 60 % 50-70% 70-99% s/p CEA
no DM 10.9% 18.8% 6.3% 1.6%
DM 8.3% 22.2% 5.6% 5.6%
no CAD 3.4% 8.6% 3.4% 0
CAD 14.1% 29.5% 7.7% 6.4%
p value .042 .0028 .467 .071
no HTN 0 20% 0 10%
HTN 8.7% 30.2% 6.3% 3.2%
DM & CAD 12.5% 30% 7.5% 10%
60 y.o. 0 7.1% 0 0
61-80 y.o. 13.2% 27.9% 5.9% 2.9%
81 y.o. 10% 17.5% 10% 7.5%
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Arteriovenous Fistulae (AVF) for Hemodialysis
Roberto J. Manson1, Mark Mantell2, Adrian Ebner3,
Prabir Roy-Chaudhury4. 1Surgery, Duke University Med-
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Philadelphia, PA; 3Italian Hospital, Asuncion, Paraguay;
4University of Cincinnati, Cincinnati, OH
Objectives: Arteriovenous fistulae (AVFs) are the pre-
ferred dialysis vascular access. Over 50% of AVFs are unsuit-
able for dialysis (”maturation failure”) at 5 months, primar-
ily due to peri-anastomotic stenosis. The objective of the
study was to evaluate the technical feasibility, safety, and
efficacy of a novel anastomotic device for the creation of
arteriovenous fistula (AVF) for hemodialysis.
